Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Simulations Plus Inc (NASDAQ:SLP)

8.53
Delayed Data
As of Sep 26
 -0.08 / -0.93%
Today’s Change
6.74
Today|||52-Week Range
11.89
-13.93%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Packaged Software
MARKET CAP
$145.5M

Company Description

Simulations Plus, Inc. is a developer of groundbreaking drug discovery and development software for mechanistic modeling and simulation. The company software is licensed to major pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies worldwide for use in the conduct of industry-based research. It also provide consulting services ranging from early drug discovery through preclinical and clinical trial data analysis and reporting to regulatory agencies. Simulations Plus was founded by Walter S. Woltosz & Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Contact Information

Simulations Plus, Inc.
42505 10th Street West
Lancaster California 93534-7059
P:(661) 723-7723
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Walter S. WoltoszChairman & Chief Executive Officer
Thaddeus Henry GraselaPresident & Director
John R. KneiselChief Financial Officer
Michael B. BolgerChief Scientific Officer
Virginia E. WoltoszSecretary & Treasurer